Kyowa Hakko Kirin Co. Ltd
(OTC: KYKOY)
|
7:40 PM UTC, 03/27/24 | |||
---|---|---|---|---|
Last: $19.80 | Change: +0.12 | %Change: +0.61% | Volume: 400 |
Open: | $ 19.80 | Volume: | 400 | |
---|---|---|---|---|
High: | $ 19.80 | Yield(%) | 1.18 | |
Low: | $ 19.80 | P/E Ratio (ttm): | 15.26 | |
Dividend ($): | n/a | Market Cap ($): | 8.67B | |
EPS ($) | 1.06 | Shares Out: | 535.04M |
% Price Change (last 4 weeks): | -7.29 |
---|---|
% Price Change (last 13 weeks): | -7.27 |
% Price Change (last 26 weeks): | -2.79 |
% Price Change (last 52 weeks): | -12.78 |
% Price Change (year to date): | -3.02 |
Return on Equity (%): | 9.86 |
---|---|
Return on Assets (%): | 8.02 |
Return on Invested Capital (%): | 7.11 |
Gross Profit Margin (%): | 72.50 |
---|---|
Net Profit Margin (%): | 18.36 |
Operating Profit Margin (%): | 21.67 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It handles the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. It also produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.
|
Kyowa Hakko Kirin Co. Ltd
Otemachi Financial City Grand Cube 1-9-2 Otemachi Chiyoda-Ku Tokyo TY 100-0004 Phone: 81.3.5205.7200 Fax: 81.3.5205.7182 http://www.kyowa-kirin.co.jp |
Earnings (1year) ($): | 1.06 |
---|---|
Annual Dividend ($): | 0.19 |
Current P/E Ratio (ttm): | 15.26 |
Book Value ($): | 11.04 |
Cash Flow ($): | 1.35 |
Price/Earnings (x): | 15.26 |
---|---|
Price/Sales (x): | 2.86 |
Price/Book (x): | 1.51 |
Price/Cash Flow (x): | 10.94 |
Quick Ratio (x): | 4.05 |
---|---|
Current Ratio (x): | 4.59 |
LT Debt/Equity (x): | 1.93 |
Total Debt/Equity (x): | 2.90 |